MARSHALL WACE, LLP - CORTEXYME INC ownership

CORTEXYME INC's ticker is CRTX and the CUSIP is 22053A107. A total of 114 filers reported holding CORTEXYME INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CORTEXYME INC
ValueSharesWeighting
Q2 2022$36,000
-99.4%
16,306
-73.1%
0.00%
-100.0%
Q3 2021$5,564,000
+171.7%
60,701
+57.0%
0.02%
+155.6%
Q2 2021$2,048,000
+107.5%
38,651
+8.7%
0.01%
+80.0%
Q4 2020$987,000
-49.1%
35,556
-8.3%
0.01%
-58.3%
Q3 2020$1,940,000
+163.9%
38,776
+144.3%
0.01%
+140.0%
Q2 2020$735,000
+390.0%
15,871
+384.0%
0.01%
+400.0%
Q1 2020$150,0003,2790.00%
Other shareholders
CORTEXYME INC shareholders Q2 2021
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 3,507,082$97,427,00015.42%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 225,000$6,251,0000.62%
AtonRa Partners 19,003$528,0000.26%
Alphabet Inc. 189,122$5,254,0000.25%
Ikarian Capital, LLC 170,000$4,722,0000.21%
Burleson & Company, LLC 41,377$1,149,0000.20%
SC US (TTGP), LTD. 1,040,343$28,901,0000.17%
COHEN LAWRENCE B 8,997$250,0000.14%
Intellectus Partners, LLC 13,950$388,0000.12%
Virtus ETF Advisers LLC 9,804$272,0000.11%
View complete list of CORTEXYME INC shareholders